Mizuho assumed coverage on shares of ZIOPHARM Oncology (NASDAQ:ZIOP) in a research note issued on Wednesday, TheFlyOnTheWall.com reports. The firm set a “buy” rating on the stock. ZIOPHARM Oncology Inc. (NASDAQ:ZIOP) shares after opening at $5.20 moved to $5.42 on last trade day and at the end of the day closed at $5.42. Company price to sales ratio in past twelve months was calculated as 641.04 and price to cash ratio as 7.52. ZIOPHARM Oncology Inc. (NASDAQ:ZIOP) showed a positive weekly performance of 22.62%.
Shares of Corcept Therapeutics (NASDAQ:CORT) were the target of a significant growth in short interest during the month of January. As of February 28th, there was short interest totalling 3,203,465 shares, a growth of 27.9% from the February 14th total of 2,504,752 shares,Analyst RN reports. Currently, 5.2% of the shares of the company are sold short. Based on an average daily trading volume, of 312,070 shares, the days-to-cover ratio is currently 10.3 days. Corcept Therapeutics Incorporated (NASDAQ:CORT) shares advanced 1.99% in last trading session and ended the day on $4.10. CORT return on equity ratio is recorded as -128.50% and its return on assets is -60.90%. Corcept Therapeutics Incorporated (NASDAQ:CORT) yearly performance is 109.18%.
Shares of Enanta Pharmaceuticals (NASDAQ:ENTA) saw a significant increase in short interest in the month of January. As of February 28th, there was short interest totalling 999,574 shares, an increase of 25.3% from the February 14th total of 797,931 shares, Stock Ratings Network reports. Approximately 12.4% of the company’s shares are sold short. Based on an average daily volume of 326,479 shares, the days-to-cover ratio is presently 3.1 days. Enanta Pharmaceuticals Inc (NASDAQ:ENTA) shares moved up 7.68% in last trading session and was closed at $42.77, while trading in range of $39.08-$43.20.Enanta Pharmaceuticals Inc (NASDAQ:ENTA) year to date performance is 56.78%.
A look at the short-term moment trend of the stock of Prothena Corporation PLC (NASDAQ:PRTA) and the earnings estimates revisions leaves no doubt that there is a lot that require attention. Thus, we dig deep to unearth the facts and figures that will enable you to make the best investment decision regarding this stock. Prothena Corporation PLC (NASDAQ:PRTA) weekly performance is 25.98%. On last trading day company shares ended up $48.30. Prothena Corporation PLC (NASDAQ:PRTA) distance from 50-day simple moving average is 54.74%.